Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

40
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

3.0K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.0K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

4.0K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.0K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

5.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

30
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet...
30
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

48
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
48

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Pleiotropic effects of phlebotropic drugs: from pharmacological advantages to adverse drug interaction].

Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery·2017
Same author

[Pneumonia at a multidisciplinary hospital].

Terapevticheskii arkhiv·2016
Same author

[Optimization of the treatment of chronic obstructive pulmonary disease in men with androgen deficiency].

Klinicheskaia meditsina·2015
Same author

[Prehospital stage of medical aid to patients with acute coronary syndrome and elevated ST segment].

Klinicheskaia meditsina·2014
Same author

[Hypertensive crisis: pathogenesis, clinic, treatment].

Kardiologiia·2013
Same author

[Experience in the pre-hospital treatment of acute coronary syndrome with metoprolol succinate].

Klinicheskaia meditsina·2013

Related Experiment Video

Updated: May 3, 2026

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

1.6K

[Hypogonadism and chronic obstructive pulmonary disease].

A L Vertkin, L Iu Morgunov, Kh A Shakhmanaev

    Urologiia (Moscow, Russia : 1999)
    |January 21, 2014
    PubMed
    Summary

    Low testosterone levels in men are linked to chronic obstructive pulmonary disease (COPD) progression. Testosterone therapy may benefit respiratory function and aid in COPD treatment and rehabilitation.

    Area of Science:

    • Pulmonary Medicine
    • Endocrinology

    Background:

    • Chronic obstructive pulmonary disease (COPD) is a systemic condition impacting more than just the lungs.
    • Androgen deficiency in men with COPD correlates with disease severity and progression.
    • Glucocorticosteroid use can worsen androgen deficiency in COPD patients.

    Purpose of the Study:

    • To investigate the relationship between testosterone levels and respiratory parameters in COPD patients.
    • To evaluate the potential benefits of androgen therapy in managing COPD.

    Main Methods:

    • Analysis of testosterone levels in relation to forced expiratory volume (FEV), hypoxemia, and hypercapnia.
    • Review of existing literature on androgen effects in COPD.
    • Consideration of hormone replacement therapy (HRT) with testosterone.

    More Related Videos

    Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
    05:34

    Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders

    Published on: August 18, 2023

    4.0K
    Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
    04:59

    Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia

    Published on: May 30, 2025

    2.2K

    Related Experiment Videos

    Last Updated: May 3, 2026

    Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
    04:53

    Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

    Published on: October 18, 2024

    1.6K
    Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
    05:34

    Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders

    Published on: August 18, 2023

    4.0K
    Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
    04:59

    Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia

    Published on: May 30, 2025

    2.2K

    Main Results:

    • Testosterone levels in COPD patients correlate significantly with FEV, hypoxemia, and hypercapnia.
    • Androgen deficiency negatively impacts COPD progression.
    • Hormone replacement therapy with testosterone is indicated for COPD patients with androgen deficiency.

    Conclusions:

    • Testosterone levels are a relevant biomarker in COPD.
    • Androgen therapy, specifically with testosterone depot (Nebido), shows promise for COPD treatment and rehabilitation.
    • Further long-term trials are warranted to confirm the efficacy of androgens in COPD management.